BAYER SAYS POSITIVE RESULTS FROM PHASE III STUDY OASIS 3 SUPPORT SUBMISSIONS FOR MARKETING AUTHORIZATION FOR ELINZANETANT
Stock Market News in real time
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
27.4 EUR | +1.88% | +4.08% | 28.74B | ||
2,686 PTS | +0.86% | +0.34% | - | ||
- Stock Market
- Stock Market News in real time
- Economy
- Bayer Says Positive Results From Phase Iii Study Oasis 3 Support…